“PlantPharm BioMed's mission is to extend the pharmaceutical industry’s market reach and patent protection by converting their current products into plant-
I believe for vaccines, this will result in an oral dose extending your market reach into previously inaccessible locations and increasing vaccine efficacy. For other biopharmaceuticals, I believe our plant production platform will reduce your costs, extend patent protection and improve your safety profile.
I invite you to sit down with us to discuss how we can partner together to accomplish these goals with a plant-
Richard R. Matner, Ph.D., MBA
President & Chief Strategy Officer
PlantPharm BioMed, Ltd.
Contact me: email@example.com